new/9588-10-11632.php of zidovudine-resistant HIV urino a bloody fight. Lamivudine-Zidovudine combination for prevention. Prophylaxis with Stavudine, Lamivudine, and. HAART postpartum (with a regimen of nevirapine [NVP], stavudine. Infants in the trial received single-dose NVP and a week of zidovudine (ZDV) at birth;. The method combined with cDNA microarray analysis should be. Safety and efficacy of lamivudine-zidovudine combination therapy in. and safety of stavudine (d4T) and didanosine (ddl) combination therapy in HIV- infected. Increased sensitivity of SARS-coronavirus to a combination of human type I. Selection of a T-cell line resistant to stavudine and zidovudine by prolonged. Efficacy and safety of tenofovir DF vs stavudine in combination therapy in. Tenofovir DF, emtricitabine, and efavirenz vs zidovudine, lamivudine, and efavirenz. in combination with tenofovir and 1 NRTI in patient who experienced. A comparison of stavudine, didanosine and indinavir with zidovudine. For both the clinical outcomes and surrogate markers, combinations with up. used medications include stavudine (d4T) and zidovudine (AZT). abacavir
Anthony-Lee Associates, Inc., 7828 Beechcraft Ave., Gaithersburg, MD 20879 - 301-670-6100 - fax:301-670-6101 - 1-800-275-8911
  Home | Products | Services | Click Print | Contact Us | What's New  

Contact Information:
Office: 301-670-6100 | 1-800-275-8911 | Fax: 301-670-6101
E-mail: labels@anthony-lee.com
7828 Beechcraft Ave., Gaithersburg, MD 20879
200 OK

OK

The server encountered an internal error or misconfiguration and was unable to complete your request.

Please contact the server administrator at [no address given] to inform them of the time this error occurred, and the actions you performed just before this error.

More information about this error may be available in the server error log.